Skip to main content
PMC home page
Scientific Reports logoLink to Scientific Reports
. 2019 Dec 5;9:18390. doi: 10.1038/s41598-019-54739-1

Oxytocin maintains lung histological and functional integrity to confer protection in heat stroke

Cheng-Hsien Lin 1, Cheng-Chia Tsai 1,2, Tzu-Hao Chen 3, Ching-Ping Chang 3,✉, Hsi-Hsing Yang 4,5,✉
PMCID: PMC6895074  PMID: 31804535

Abstract

Oxytocin (OT) has been reported to have a protective effect in lipopolysaccharide-induced experimental acute lung injury (ALI). However, its role in heat stroke-related ALI has never been investigated. Herein, we aimed to explore the therapeutic effects and potential mechanism of action of OT on heat-induced ALI. Rats were treated with OT 60 min before the start of heat stress (42 °C for 80 min). Twenty minutes after the termination of heat stress, the effects of OT on lung histopathological changes, edema, acute pleurisy and the bronchoalveolar fluid levels of inflammatory cytokines and indicators of ischemia, cellular damage, and oxidative damage were assessed. We also evaluated the influence of OT pretreatment on heat-induced hypotension, hyperthermia, ALI score, and death in a rat model of heat stroke. The results showed that OT significantly reduced heat-induced lung edema, neutrophil infiltration, hemorrhage score, myeloperoxidase activity, ischemia, and the levels of inflammatory and oxidative damage markers in bronchoalveolar lavage fluid. The survival assessment confirmed the pathophysiological and biochemical results. An OT receptor antagonist (L-368,899) was administered 10 min before the OT injection to further demonstrate the role of OT in heat-induced ALI. The results showed that OT could not protect against the aforementioned heat stroke responses in rats treated with L-368,899. Interestingly, OT treatment 80 min after the start of heat shock did not affect survival. In conclusion, our data indicate that OT pretreatment can reduce the ischemic, inflammatory and oxidative responses related to heat-induced ALI in rats.

Subject terms: Environmental impact, Molecular medicine

Introduction

Oxytocin (OT) is a neuropeptide of 9 amino acids synthesized in the paraventricular and supraoptic nuclei of the hypothalamus1,2. OT has activity in uterine contraction during parturition and the milk-ejection reflex during lactation and has beneficial effects in reducing anxiety and stress disorders2 and hepatic3, cardiac4, myocardial5, renal6, and cerebral ischemia/reperfusion injury7,8. Since OT possesses anti-inflammatory, antiapoptotic and antioxidant properties9,10, it is hypothesized to be a beneficial agent for reducing ischemia/reperfusion injury.

Studies have indicated that ischemia/reperfusion injury in several vital organs, including the intestines, lungs, and brain, is the leading cause of heat stroke11–14. Patients with heat stroke present with acute lung injury (ALI) characterized by lung edema, neutrophil infiltration and hemorrhage14. Recent reports have also noted ALI in the lungs of baboons15 and rats16 during heat stroke. A more recent report demonstrated that OT protects against ALI in mice treated with lipopolysaccharide (LPS)17. Since heat stroke resembles LPS-induced sepsis in many aspects15,16, OT pretreatment may protect against heat-induced ALI.

To address this hypothesis, we assessed the temporal profiles of edema (e.g., lung water content and Evans blue dye extravasation), acute pleurisy (e.g., exudate volume and polymorphonuclear [PMN] cell accumulation), and the levels of ischemia indicators (e.g., glutamate and lactate/pyruvate ratio), cellular damage indicators (e.g., glycerol and lactate dehydrogenase), inflammatory cytokines (e.g., tumor necrosis factor-alpha [TNF-α], interleukin-1β [IL-1β], IL-6, IL-10, and myeloperoxidase [MPO] activity), and oxidative damage indicators (e.g., nitric oxide [NO] and dihydroxybenzoic acid [DHBA]) in the bronchoalveolar fluid (BALF) of rats pretreated or post-treated with OT. We also evaluated the influence of OT therapy on heat-induced hypotension, hyperthermia, ALI score, and death in a rat model. The OT receptor antagonist (L-368,899) was given 10 min before OT to further demonstrate the role of OT in heat-induced ALI in rats17.

Results

OT reduced heat-induced death, hyperthermia and hypotension

The percent survival was first analyzed to investigate the ability of OT pretreatment to reduce the lethality of experimental heat stroke. Compared to the heated controls, the heated rats pretreated with OT (5 μg, 20 μg, or 80 μg/mL/kg body weight, i.v.) showed a significant dose-dependently increase in percent survival (Fig. 1). However, when OT (20 µg/mL/kg body weight, i.v.) was administered to heated rats at the end of the heat stress period (80 min after the start of heat stress), the increase in percent survival was not significant (Fig. 1). Additionally, the beneficial effects of OT pretreatment were significantly reduced by L-368,899 treatment 10 min before OT injection, as demonstrated in L-368,899 + OT + heated rats (Fig. 1).

Figure 1.

Figure 1

Open in a new tab

Percent survival determined by Kaplan-Meier analysis in each group (n = 10 per group). bP < 0.01, V + heated group vs. V + nonheated group; eP < 0.01, OT (20 μg/mL/kg) or OT (80 μg/mL/kg) + heated group vs. V + heated group; dP < 0.05, L-368,899 + OT + (20 µg/mL/kg) + heated group vs. V + OT (20 µg/mL/kg) + heated group. All the rats in the V + nonheated group survived for more than 300 min. Please see the explanations of the groups in the Methods section. OT = oxytocin.

One hundred minutes after the start of heat stress (or 20 min after termination of the 80-min heat shock), the vehicle-treated heated rats had a significantly higher core temperature (Tco) (42.2 °C vs. 36 °C) and a significantly lower mean arterial pressure (MAP) (28 mmHg vs. 86 mmHg) and HR (~150 beats/min vs. ~500 beats/min) than the vehicle-treated nonheated rats (Fig. 2). However, compared to the vehicle (V) + heated group, the OT (20 μg/mL/kg) + heated group had a significantly lower Tco (40.5 °C vs. 42.2 °C) but a significantly higher MAP (90 mmHg vs. 28 mmHg) and HR (410 beats/min vs. 135 beats/min). Again, the beneficial effect of OT treatment prior to heat stroke was significantly reduced by L-368,899 pretreatment (Fig. 2). It can be seen from Fig. 2 that at 80 min after heat shock, compared to the V + heated group, the V + OT + heated group had a slight change in both MAP and heart rate. However, at 100 min post-heat shock, the OT + heated group had significantly higher values of both MAP and heart rate than did the V + heated group.

Figure 2.

Figure 2

Open in a new tab

Changes in ambient temperature (A, Ta), colon temperature (B, Tco), MAP (C) and heart rate (D, HR) in the V + nonheated, V + heated, V + OT + heated, and L-368,899 + OT + heated groups. The Tco (E) and MAP (F) were obtained 0, 80, and 100 min after the initiation of heat exposure (ambient temperature in nonheated controls) in heatstroke rats. All heated groups were exposed to heat (42 °C) for exactly 80 min and were then allowed to recover at room temperature (26 °C). Data are presented as the mean ± SD of 10 rats per group. bP < 0.05 compared with the V + nonheated group; eP < 0.05 compared with the V + heated group; dP < 0.05 compared with the V+ OT + heated group. Please see the explanations of the groups in the Methods section. V = vehicle; i.v. = intravenous.

OT alleviated heat-induced ALI

The pulmonary edema, neutrophil and hemorrhage scores were significantly higher in the V + heated group than in the nonheated control group (Fig. 3). The heat-induced increases in lung edema, neutrophil and hemorrhage scores were all significantly reduced by OT pretreatment, as demonstrated by the V + OT + heated group (Fig. 3). However, the beneficial effects of OT in reducing ALI were significantly reversed by pretreatment with the OT antagonist L-368,899 (Fig. 3).

Figure 3.

Figure 3

Open in a new tab

Lung edema, neutrophil infiltration and hemorrhagic scores in different groups of rats. (A) Representative microscopic images of the lungs from rats in the V + nonheated, V + heated, V + OT + heated and L-368,899 + OT + heated groups. (B) Data are presented as the mean ± SD (n = 10). bP < 0.05, V + heated group vs. V + nonheated group; eP < 0.05, V + OT + heated group vs. V + heated group; dP < 0.05 compared to the L-368,899 + OT + heated group.

OT reduced the heat-induced increases in BALF levels of PMN cell number and proinflammatory cytokines and in lung MPO activity

Compared with the nonheated control group, the V + heated group had significantly higher exudate volume, PMN cell number and proinflammatory cytokine levels in BALF and lung MPO activity (Table 1). Compared with the V + heated group, the V + OT + heated group had significantly lower exudate volume, PMN cell number and proinflammatory cytokine levels in BALF and lung MPO activity (Table 1). The beneficial effects of OT in reducing acute inflammatory responses to heat stress were all attenuated by L-368,899 pretreatment (Table 1).

Table 1.

Exudate volume, PMN cell number, MPO activity in lung tissue, and TNF-α, IL-1β, IL-6 and IL-10 levels in BALF from the V + nonheated, V + heated (42 °C for 80 min), V + OT (20 µg/kg) + heated and L-368,899 + OT (20 µg/kg) + heated groups.

Parameters V + nonheated V + heated V + OT + heated L-368,899 + OT + heated
1. Exudate volume (mL) 0.3 ± 0.1 3.2 ± 0.2b 1.5 ± 0.2e 3.4 ± 0.3d
2. PMN cells (million cells/rat) 15 ± 6 174 ± 8b 82 ± 6e 181 ± 9d
3. MPO activity (μg/mg protein) 97 ± 14 326 ± 17b 133 ± 19e 329 ± 18d
4. TNF-α (pg/mL) 9 ± 2 69 ± 4b 22 ± 5e 72 ± 5d
5. IL-1β (pg/mL) 18 ± 3 77 ± 5b 24 ± 4e 80 ± 6d
6. IL-6 (pg/mL) 12 ± 1 78 ± 3b 26 ± 3e 79 ± 4d
7. IL-10 (pg/mL) 31 ± 5 57 ± 6b 123 ± 8e 53 ± 5d
Open in a new tab

Data are presented as the mean and SD for ten rats/group. bP < 0.05 compared with the V + nonheated group; eP < 0.05 compared with the V + heated group; dP < 0.05 compared with the V + OT + heated group.

Rats were sacrificed 100 min after the initiation of heat stress by an overdose of anesthetic, and the samples were collected for biochemical determination.

OT downregulated the heat-induced increase in BALF levels of cellular ischemia and damage markers and nitrogen and oxygen free radical species

Compared with the V + nonheated group, the V + heated group had significantly higher BALF levels of cellular ischemia indicators (e.g., glutamate and lactate/pyruvate), cellular damage indicators (e.g., glycerol) and nitrogen and oxygen radical species (e.g., NO metabolites and DHBA) (Table 2). The heat-induced lung ischemia and oxidative damage were significantly alleviated by OT pretreatment. Again, L-368,899 significantly reversed the beneficial effects of OT (Table 2).

Table 2.

Lactate/pyruvate ratio and the levels of glutamate, glycerol, lactate dehydrogenase, NO metabolites, and DHBA in BALF from the V + nonheated, V + heated (42 °C for 80 min), OT (20 μg/kg) + heated and L-368,899 + OT (20 μg/kg) + heated groups.

Parameters V + nonheated V + heated V + OT + heated L-368,899 + OT + heated
1. Glutamate (% of baseline) 100 ± 18 422 ± 26b 153 ± 23e 430 ± 27d
2. Lactate/pyruvate ratio (% of baseline) 100 ± 9 199 ± 12b 124 ± 11e 207 ± 14d
3. Glycerol (% of baseline) 100 ± 8 185 ± 9b 112 ± 6e 199 ± 10d
4. Nitric oxide metabolites (% of baseline) 100 ± 11 453 ± 24b 149 ± 19e 463 ± 25d
5. 2,3-Dihydroxybenzoic acid (% of baseline) 100 ± 14 207 ± 22b 138 ± 16e 215 ± 23d
Open in a new tab

The results are presented as the mean ± SD (N = 10). bP < 0.05 compared with the V + nonheated group; eP < 0.05 compared with the V + heated group; dP < 0.05 compared with the V + OT + heated group.

Rats were sacrificed 100 min after the initiation of heat stress by an overdose of anesthetic, and the samples were collected for biochemical determination.

OT decreased heat-induced lung edema

The lung water content due to edema was higher in the V + heated group than in the V + nonheated group (P < 0.05, Fig. 4A). The V + OT + heated group had a significantly lower lung water content than the V + heated group (P < 0.05, Fig. 4A). Evans blue dye extravasation assays were conducted to evaluate blood-lung barrier permeability. The V + heated group had more extravasated dye in the lung specimen than did the V + nonheated group (Fig. 4B). Treatment with OT preserved blood-lung barrier integrity in the V + OT + heated group, as shown by the significant reduction in Evans blue dye extravasation compared to the V + heated group (P < 0.05, Fig. 4B). Again, the beneficial effects of OT were significantly reduced by L-368,899 treatment (P < 0.05, Fig. 4).

Figure 4.

Figure 4

Open in a new tab

Lung water content (A) and Evans blue dye extravasation (B) in different groups of rats. All heated groups were exposed to heat for exactly 80 min and then allowed to recover at room temperature. Data are presented as the mean ± SD of 10 rats per group. bP < 0.05, V + heated group vs. V + nonheated group; eP < 0.05, V + OT + heated group vs. V + heated group; dP < 0.05, L-368,899 + OT + heated group vs. V + OT + heated group.

Discussion

Accumulated evidence indicates that severe heat stress causes splanchnic vasoconstriction and arterial hypotension and results in bacterial translocation from the intestine to the blood stream18. Increased plasma endotoxin levels promote the pulmonary recruitment and activation of PMN cells16,19 and the overproduction of pulmonary proinflammatory cytokines20,21 and reactive nitrogen and oxygen species22,23. Indeed, our present results confirmed that rats with heat stroke displayed (i) hyperthermia and hypotension; (ii) acute pleurisy and lung edema; (iii) increased lung edema, neutrophil infiltration and hemorrhage scores; (iv) pulmonary inflammatory, ischemic and oxidative injury; and (v) decreased survival. The present study revealed a novel finding that pretreatment with OT increased survival, decreased both hyperthermia and hypotension, decreased acute pleurisy, and decreased acute lung edema, ischemia, and inflammatory and oxidative damage in heated rats. An OT receptor antagonist (L-368,899) was administered 10 min before the OT injection to further demonstrate the role of OT in heat-induced ALI; under these conditions, OT could not alleviate the aforementioned ALI. Interestingly, treatment with OT at the end of the heat shock period did not increase survival. In conclusion, our data suggest that OT pretreatment can reduce heat-induced ALI responses in rats.

Heat stroke reactions resemble LPS- or endotoxin-induced septic shock in many aspects24. Indeed, OT protects against ALI caused by endotoxin-induced septic shock in rats4,25,26. OT alleviates hepatic3, cardiac4,5, renal6, gastric27 and cerebral1 ischemia/reperfusion injury as well as septic shock3,6,27 in rodents by acting as an anti-inflammatory and/or antioxidant agent. OT reduced the inflammatory responses related to LPS-induced ALI in a mouse model17. Specifically, OT decreased the release of IL-1β and IL-6 but increased the release of anti-inflammatory cytokines such as IL-4 and IL-10. In ALI, neutrophils are the earliest immune cells recruited to the lungs. MPO activity is an indicator of neutrophil accumulation in tissue. LPS-induced lung histopathological injury, edema, neutrophil infiltration and MPO activity were all significantly decreased by OT. Moreover, the anti-inflammatory effects of OT in LPS-induced ALI were effectively blocked by the OT receptor antagonist L-368,899.

OT also exerts neuroprotective28, cardioprotective4 and pulmonary protective17 effects during ischemia/reperfusion injury, but treatment must be initiated prior to the induction of injury. The results presented herein show that OT administration before the induction of regional ischemia and reperfusion reduced the extent of tissue injury by a mechanism involving the activation of OT-specific receptors. Additionally, in our study, lung injury was not reduced in heated rats treated with OT after the onset of heat stroke, indicating that the induction of new genes is not necessary for the pulmonary protective effect of OT.

Although OT and OT receptors exert neuroprotective, cardioprotective and pulmonary protective activities, the variety and multiplicity of effects induced by OT and its receptors suggest that their roles in physiology and pathology are not fully understood29; the best-known and most well-established roles are the stimulation of uterine contraction during parturition and milk release during lactation. Activation of the OT receptor causes myometrial contractions. Atosiban is currently the only OT receptor antagonist that is available as a tocolytic. L-368,899, a potent non-peptide OT antagonist, inhibited spontaneous nocturnal uterine contractions in pregnant rhesus monkeys and blocked OT-stimulated postpartum uterine activity in women30; it also altered maternal and sexual behavior in one adult monkey31. Although several studies tend to indicate that OT combined with OT receptors have promise to improve the management of ALI17, myocardial injury4 and cerebral ischemia8, it may exert its actions via the neurohumoral system and different variety of receptors other than OT receptors. For example, oxytocin may pass the blood-brain barrier to exert its action32,33. Oxytocin in high concentrations may induce pressor effects by binding to vasopressin (V1a) receptors34. The vasoconstriction effect of OT of more than 10−6 M could be completely blocked by V1 receptor antagonists35. In contrast, OT inhibits the rat medullary dorsal horn nociceptive transmission through OT but not V1a receptors36. Thus, the exact mechanisms behind the pulmoprotective effects of OT in heated rat remain to be explored in future investigation.

We noted that OT protects against heat-induced hypotension, which suggests the potential for OT as a preventive strategy for heat stroke. Both patients37 and rodents38 display arterial hypotension during heat stroke. A more recent report showed that arterial hypotension occurs at the onset of severe heat stroke due to decreased cardiac mechanical efficiency and arterial elastance39. Thus, OT preconditioning might attenuate arterial hypotension in rats experiencing heat stroke by the same type of mechanism.

Compared with the normothermic control rats in the present study, the vehicle-treated heated rats had more severe cellular ischemia (e.g., glutamate and lactate/pyruvate ratio) and damage (e.g., glycerol); higher levels of prooxidant enzymes (e.g., lipid peroxidation and glutathione oxidation markers), proinflammatory cytokines (e.g., IL-1β, IL-6 and TNF-α) and NO in BALF; and greater PMN leukocyte accumulation (e.g., MPO activity) in lung tissue. However, indicators of pulmonary antioxidant defense (e.g., glutathione peroxidase and glutathione reductase) were lower. Thus, it appears that OT preconditioning confers protection against heat stroke in rats by attenuating heat-induced inflammatory, ischemic and oxidative damage to the lungs.

The present study demonstrated that OT binding to OT receptors has a protective effect against heat-induced ALI by inhibiting the ischemic, oxidative and inflammatory responses in a rat model. The mechanism might involve TLR4/NLRP3/NF-κB, Bax/p53, Bcl-240,41, type A gamma-aminobutyric acid receptor28, calpain-17, and carbonic anhydrase and acetylcholinesterase enzymes42.

Environmental heat stress increases cutaneous blood flow and metabolism and progressively decreases splanchnic blood flow24. Tissue ischemia, rather than hyperthermia, is the main cause of heat stroke. In the present study, OT attenuated ALI in heated rats potentially by reducing ischemic injury (secondary to maintaining an adequate MAP). However, the possibility that OT protects against heat-induced ALI by reducing hyperthermia from ~42 °C to ~40 °C cannot be ruled out.

In humans, studies are lacking on the effects of chronic OT administration on blood pressure. However, short-term intravenous administration of OT to women to enhance uterine contraction or decrease blood loss during labor or cesarean delivery decreased blood pressure43–45. The hypotensive response to OT is due to decreases in total vascular resistance, stroke volume and cardiac output46. On the other hand, plasma OT is related to lower cardiovascular and sympathetic reactivity during public speaking and the forehead cold pressor test in women47. In anesthetized rats, OT pretreatment did not reliably increase MAP during pre-ischemia/reperfusion injury, but it did significantly attenuate cardiac ischemia/reperfusion injury4. As shown in Fig. 2C,D, OT does not affect either MAP or HR up to 80 minutes. After 100 minutes, both MAP and HR of OT antagonist treated or sham-treated group decline. The changes in hemodynamic markers might be the result of organ failure and not cause of mortality. Moreover, MAP and HR changes of OT antagonist group are comparable with OT heated group. This highly suggests that OT protective effect is independent of hemodynamics. So the beneficial effects of OT on the ischemic lung tissues are likely depended upon direct cytoprotection at the cellular levels. The possible mechanisms, such as involvement of V1a receptor, redistribution of the blood flow and/or hyperthermia in relation to ALI should be emphysized in future experisments.

As for the half time of OT, it may be short and with 60 minutes before heat shock, oxytocin level should be half, and when considering their survival time, the effect of OT may be limited due to its low in concentration. However, according to the findings of Morin et al.48, a single intravenous bolus of OT was given at a dose of 10000 ng/kg to anesthetized male rats. Blood sample were taken over 72 min to 150 min. The plasma OT concentrations in rats were downed to the ~1000 ng/kg at time “140 min”. Based on their pharmacokinetic properties, in our present study, 80 minutes after an i.v. dose of 20 μg/kg or 20000 ng/kg of OT would have a plasma level of OT at ~2000 ng/kg. Additionally, 2 h after an i.p. dose of OT (0.1 mg/kg) preatment significantly protected against the lipopolysaccharide-induced acute lung injury17. Putting these observations together, the dosage of OT used in the present study seems adequate for protecting against heat-induced ALI in rats.

Conclusion

Anesthetized rats were exposed to OT before the induction of ALI in an experimental heat stroke model. Pretreatment with OT ameliorated heat-induced acute lung edema, neutrophil infiltration, hemorrhage injury and death. However, OT administration during heat exposure did not induce pulmonary protection. The OT receptor antagonist (L-368,899) was administered 10 min before injecting OT to further demonstrate the role of OT in heat-induced ALI, and the results showed that OT could not alleviate ALI and death under these conditions. In conclusion, the present results indicate that OT can reduce the ischemic, inflammatory and oxidative responses related to heat-induced ALI in rats.

Materials and Methods

Ethics review and approval

The Institutional Animal Care and Use Committee of Chi Mei Medical Center (Tainan, Taiwan) approved this work, which was performed according to the Institutional and National Ministry of Science and Technology guidelines for laboratory animal care.

Materials

OT was purchased from Apex Bio (TX, USA). The OT receptor antagonist L-368,899 (purity ≥ 98%) was purchased from Sigma (MO, USA).

Animals

Male Sprague-Dawley rats (weighing 358–376 g) were purchased from the Animal Resource Center of Chi Mei Medical Center. The animals were housed in a temperature-controlled room with a 12-h light/dark cycle and free access to food and water. The animals were acclimated for at least 1 week before the start of experimentation. In all experiments, adequate anesthesia was maintained by one or more doses of sodium pentobarbital (40 mg/kg body weight, i.p.) to abolish the corneal reflex and pain reflexes induced by tail pinching.

Assessment of physiological parameters

Blood pressure monitoring and drug treatment were accomplished via the cannulated femoral artery and vein, respectively. A thermocouple and pressure transducer were used to continuously measure the Tco and MAP.

Induction of heatstroke

Anesthetized rats were exposed to a folded heating pad at 42 °C for 80 min to induce heat stroke, as depicted in Fig. 1. Then, the folded heating pad temperature was kept at ~26 °C. Twenty minutes post heat stress (i.e., 100 min after the start of heat stress), animals displayed heatstroke symptoms of excessive hyperthermia (e.g., Tco: ~42.4 °C) and arterial hypotension (e.g., MAP: ~35 mmHg)12,18. We determined the percent survival for all groups.

Experimental groups

After adaption, all rats were randomly divided into five groups (n = 10 in each group), and all drugs were injected intravenously: (A) control or vehicle-treated nonheated group (V + nonheated; saline 10 min and 60 min before the start of experimentation; 26 °C); (B) V + heated group (saline (1 mL/kg) 10 min and 60 min before the start of heat stress (42 °C for 80 min); (C) OT + heated group (saline 10 min and OT (5 μg/mL/kg, 20 μg/mL/kg or 80 μg/mL/kg) 60 min before the start of heat stress (42 °C for 80 min); (D) L-368,899 + OT + heated group (L-368,899 (5 mg/kg) 10 min and OT (20 μg/mL/kg) 60 min before the start of heat stress (42 °C for 80 min); and (E) heated + OT group (20 μg/mL/kg OT 80 min after the start of heat stress (42 °C for 80 min).

Lung morphology

The right upper lung was removed, fixed in 10% buffered formalin, embedded in paraffin, cut into 3-μm-thick sections and stained with hematoxylin and eosin (HE). The pathological changes in the lungs were observed using an optical microscope. The histological scoring parameters included edema, neutrophil infiltration and alveolar hemorrhage and were scored by the methods of Matute-Bello et al.49.

Lung water content

The severity of lung edema was assessed by the wet weight/dry weight ratio as reported previously20. The lung wet weight was measured, and then, the lungs were placed in an oven at 100 °C for 24 h to obtain the dry weight and calculate the wet/dry weight ratio.

Evans blue dye extravasation assay

The Evans blue dye extravasation assay was conducted by previously described methods21. An intravenous dose of 0.2 mL Evans blue dye (4%) was administered to the anesthetized animals 3 h before sacrifice. A spectrophotometer (Thermo Fischer Scientific Inc., Waltham, MA, USA) was used to quantify the amount of extravasated Evans blue dye in the lungs.

MPO activity in lung tissue

As an indicator of neutrophil infiltration, MPO activity in the ischemic lung tissue was determined as previously described22.

Measurement of cytokines, cellular ischemia and damage markers, and oxidative damage indicators in BALF

The BALF concentrations of cytokines (e.g., TNF-α, IL-1β, IL-6 and IL-10) and indicators of ischemia (e.g., glutamate and lactate/pyruvate ratio), cellular damage (e.g., glycerol), and oxidative damage (e.g., NO metabolites and DHBA) were determined according to previous reports16,23.

Statistical analysis

We performed all statistical data analyses with GraphPad Prism 7.01 (GraphPad Software Inc., CA, USA). Data from multiple independent experiments are expressed as the mean ± standard deviation (SD). Percent survival was compared using Kaplan-Meier analysis followed by the log-rank test. One-way analysis of variance followed Tukey’s multiple comparisons test was performed to analyze differences among multiple groups. Significant differences were established at P < 0.05.

Acknowledgements

Our study was supported by grants from the Ministry of Science and Technology of the Republic of China (MOST 108-2314-B-715-001 and MOST 107-2314-B-384-007-MY3), Chi Mei Medical Center (Taiwan) (no. CMF 1040530 and CMFHT10504) and Mackay Memorial Hospital (MMH-MM-10807).

Author contributions

Study Design: Cheng-Hsien Lin. Performed the Experiments & Data Collection: Cheng-Hsien Lin, Tzu-Hao Chen. Statistical Analysis: Cheng-Chia Tsai, Tzu-Hao Chen. Data Interpretation: Cheng-Hsien Lin, Hsi-Hsing Yang. Manuscript Preparation: Ching-Ping Chang, Hsi-Hsing Yang.

Data availability

The corresponding authors will provide data upon reasonable request.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Ching-Ping Chang, Email: jessica.cpchang@gmail.com.

Hsi-Hsing Yang, Email: zbw@stust.edu.tw.

References

  • 1.Li T, Wang P, Wang SC, Wang YF. Approaches Mediating Oxytocin Regulation of the Immune System. Frontiers in immunology. 2016;7:693. doi: 10.3389/fimmu.2016.00693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Donadon MF, Martin-Santos R, Osorio FL. The Associations Between Oxytocin and Trauma in Humans: A Systematic Review. Front Pharmacol. 2018;9:154. doi: 10.3389/fphar.2018.00154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Dusunceli F, et al. Oxytocin alleviates hepatic ischemia-reperfusion injury in rats. Peptides. 2008;29:1216–1222. doi: 10.1016/j.peptides.2008.02.010. [DOI] [PubMed] [Google Scholar]
  • 4.Houshmand F, Faghihi M, Zahediasl S. Biphasic protective effect of oxytocin on cardiac ischemia/reperfusion injury in anaesthetized rats. Peptides. 2009;30:2301–2308. doi: 10.1016/j.peptides.2009.09.010. [DOI] [PubMed] [Google Scholar]
  • 5.Ondrejcakova M, Ravingerova T, Bakos J, Pancza D, Jezova D. Oxytocin exerts protective effects on in vitro myocardial injury induced by ischemia and reperfusion. Canadian journal of physiology and pharmacology. 2009;87:137–142. doi: 10.1139/y08-108. [DOI] [PubMed] [Google Scholar]
  • 6.Tugtepe H, et al. The protective effect of oxytocin on renal ischemia/reperfusion injury in rats. Regulatory peptides. 2007;140:101–108. doi: 10.1016/j.regpep.2006.11.026. [DOI] [PubMed] [Google Scholar]
  • 7.Etehadi Moghadam S, et al. Neuroprotective Effects of Oxytocin Hormone after an Experimental Stroke Model and the Possible Role of Calpain-1. J Stroke Cerebrovasc Dis. 2018;27:724–732. doi: 10.1016/j.jstrokecerebrovasdis.2017.10.020. [DOI] [PubMed] [Google Scholar]
  • 8.Karelina K, et al. Oxytocin mediates social neuroprotection after cerebral ischemia. Stroke. 2011;42:3606–3611. doi: 10.1161/strokeaha.111.628008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Erkanli Senturk G, et al. The protective effect of oxytocin on ischemia/reperfusion injury in rat urinary bladder. Peptides. 2013;40:82–88. doi: 10.1016/j.peptides.2012.12.006. [DOI] [PubMed] [Google Scholar]
  • 10.Gonzalez-Reyes A, et al. Molecular mechanisms underlying oxytocin-induced cardiomyocyte protection from simulated ischemia-reperfusion. Mol Cell Endocrinol. 2015;412:170–181. doi: 10.1016/j.mce.2015.04.028. [DOI] [PubMed] [Google Scholar]
  • 11.Bouchama A, Knochel JP. Heat stroke. N Engl J Med. 2002;346:1978–1988. doi: 10.1056/NEJMra011089. [DOI] [PubMed] [Google Scholar]
  • 12.Singh LP, Kapoor M, Singh SB. Heat: not black, not white. It’s gray!!! J Basic Clin Physiol Pharmacol. 2013;24:209–224. doi: 10.1515/jbcpp-2012-0080. [DOI] [PubMed] [Google Scholar]
  • 13.Leon LR, Bouchama A. Heat stroke. Compr Physiol. 2015;5:611–647. doi: 10.1002/cphy.c140017. [DOI] [PubMed] [Google Scholar]
  • 14.Varghese GM, John G, Thomas K, Abraham OC, Mathai D. Predictors of multi-organ dysfunction in heatstroke. Emerg Med J. 2005;22:185–187. doi: 10.1136/emj.2003.009365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Roberts GT, et al. Microvascular injury, thrombosis, inflammation, and apoptosis in the pathogenesis of heatstroke: a study in baboon model. Arterioscler Thromb Vasc Biol. 2008;28:1130–1136. doi: 10.1161/atvbaha.107.158709. [DOI] [PubMed] [Google Scholar]
  • 16.Yang HS, Chang CP, Cheng JT, Lin MT. Inhibition of acute lung inflammation and injury is a target of brain cooling after heatstroke injury. J Trauma. 2010;69:805–812. doi: 10.1097/TA.0b013e3181cb43fd. [DOI] [PubMed] [Google Scholar]
  • 17.An X, et al. Protective effect of oxytocin on LPS-induced acute lung injury in mice. Sci Rep. 2019;9:2836. doi: 10.1038/s41598-019-39349-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hall DM, et al. Mechanisms of circulatory and intestinal barrier dysfunction during whole body hyperthermia. Am J Physiol Heart Circ Physiol. 2001;280:H509–521. doi: 10.1152/ajpheart.2001.280.2.H509. [DOI] [PubMed] [Google Scholar]
  • 19.Shang Y, et al. Melatonin reduces acute lung injury in endotoxemic rats. Chin Med J (Engl) 2009;122:1388–1393. [PubMed] [Google Scholar]
  • 20.Wright RM, et al. Mononuclear phagocyte xanthine oxidoreductase contributes to cytokine-induced acute lung injury. Am J Respir Cell Mol Biol. 2004;30:479–490. doi: 10.1165/rcmb.2003-0309OC. [DOI] [PubMed] [Google Scholar]
  • 21.Shinbori T, Walczak H, Krammer PH. Activated T killer cells induce apoptosis in lung epithelial cells and the release of pro-inflammatory cytokine TNF-alpha. Eur J Immunol. 2004;34:1762–1770. doi: 10.1002/eji.200425097. [DOI] [PubMed] [Google Scholar]
  • 22.Haddad IY, et al. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest. 1994;94:2407–2413. doi: 10.1172/jci117607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Matthay MA, Geiser T, Matalon S, Ischiropoulos H. Oxidant-mediated lung injury in the acute respiratory distress syndrome. Crit Care Med. 1999;27:2028–2030. doi: 10.1097/00003246-199909000-00055. [DOI] [PubMed] [Google Scholar]
  • 24.Chen SH, Lin MT, Chang CP. Ischemic and oxidative damage to the hypothalamus may be responsible for heat stroke. Curr Neuropharmacol. 2013;11:129–140. doi: 10.2174/1570159x11311020001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Liu D, Zeng BX, Shang Y. Decreased expression of peroxisome proliferator-activated receptor gamma in endotoxin-induced acute lung injury. Physiol Res. 2006;55:291–299. doi: 10.33549/physiolres.930822. [DOI] [PubMed] [Google Scholar]
  • 26.Iseri SO, et al. Oxytocin protects against sepsis-induced multiple organ damage: role of neutrophils. J Surg Res. 2005;126:73–81. doi: 10.1016/j.jss.2005.01.021. [DOI] [PubMed] [Google Scholar]
  • 27.Wenwen Z, Zhang J, Xu M, Zhang Y. Effect of oxytocin on gastric ischemia-reperfusion injury in rats. Front Med China. 2007;1:433–437. doi: 10.1007/s11684-007-0085-4. [DOI] [PubMed] [Google Scholar]
  • 28.Kaneko Y, Pappas C, Tajiri N, Borlongan CV. Oxytocin modulates GABAAR subunits to confer neuroprotection in stroke in vitro. Sci Rep. 2016;6:35659. doi: 10.1038/srep35659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Szylberg Ł, Michalski J, Maciejewska M, Marszałek A. Oxytocin and its role and effects - recent findings. Archives of Perinatal Medicine. 2013;19:43–49. [Google Scholar]
  • 30.Williams PD, Bock MG, Evans BE, Freidinger RM, Pettibone DJ. Progress in the development of oxytocin antagonists for use in preterm labor. Advances in experimental medicine and biology. 1998;449:473–479. doi: 10.1007/978-1-4615-4871-3_61. [DOI] [PubMed] [Google Scholar]
  • 31.Boccia ML, Goursaud AP, Bachevalier J, Anderson KD, Pedersen CA. Peripherally administered non-peptide oxytocin antagonist, L368,899, accumulates in limbic brain areas: a new pharmacological tool for the study of social motivation in non-human primates. Hormones and behavior. 2007;52:344–351. doi: 10.1016/j.yhbeh.2007.05.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Petersson M, Lundeberg T, Uvnas-Moberg K. Short-term increase and long-term decrease of blood pressure in response to oxytocin-potentiating effect of female steroid hormones. Journal of cardiovascular pharmacology. 1999;33:102–108. doi: 10.1097/00005344-199901000-00015. [DOI] [PubMed] [Google Scholar]
  • 33.Uvnas-Moberg K. Antistress Pattern Induced by Oxytocin. News in physiological sciences: an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society. 1998;13:22–25. doi: 10.1152/physiologyonline.1998.13.1.22. [DOI] [PubMed] [Google Scholar]
  • 34.Petersson M, Uvnas-Moberg K. Effects of an acute stressor on blood pressure and heart rate in rats pretreated with intracerebroventricular oxytocin injections. Psychoneuroendocrinology. 2007;32:959–965. doi: 10.1016/j.psyneuen.2007.06.015. [DOI] [PubMed] [Google Scholar]
  • 35.Costa ESRH, et al. Cardiac effects of oxytocin: is there a role for this peptide in cardiovascular homeostasis? Regulatory peptides. 2005;132:107–112. doi: 10.1016/j.regpep.2005.09.011. [DOI] [PubMed] [Google Scholar]
  • 36.Garcia-Boll E, Martinez-Lorenzana G, Condes-Lara M, Gonzalez-Hernandez A. Oxytocin inhibits the rat medullary dorsal horn Sp5c/C1 nociceptive transmission through OT but not V1A receptors. Neuropharmacology. 2018;129:109–117. doi: 10.1016/j.neuropharm.2017.11.031. [DOI] [PubMed] [Google Scholar]
  • 37.Dematte JE, et al. Near-fatal heat stroke during the 1995 heat wave in Chicago. Ann Intern Med. 1998;129:173–181. doi: 10.7326/0003-4819-129-3-199808010-00001. [DOI] [PubMed] [Google Scholar]
  • 38.Chen SH, Niu KC, Lin MT. Cerebrovascular dysfunction is an attractive target for therapy in heat stroke. Clin Exp Pharmacol Physiol. 2006;33:663–672. doi: 10.1111/j.1440-1681.2006.04429.x. [DOI] [PubMed] [Google Scholar]
  • 39.Hsu SF, Chao CM, Chang CP, Lin MT, Cheng BC. Heat shock protein 72 may improve hypotension by increasing cardiac mechanical efficiency and arterial elastance in heatstroke rats. Int J Cardiol. 2016;219:63–69. doi: 10.1016/j.ijcard.2016.05.004. [DOI] [PubMed] [Google Scholar]
  • 40.Alizadeh AM, et al. Oxytocin protects cardiomyocytes from apoptosis induced by ischemia-reperfusion in rat heart: role of mitochondrial ATP-dependent potassium channel and permeability transition pore. Peptides. 2012;36:71–77. doi: 10.1016/j.peptides.2012.03.023. [DOI] [PubMed] [Google Scholar]
  • 41.Mostafa DG, Khaleel EF, Abdel-Aleem GA. Mechanism of action of oxytocin as cardioprotection in rat model of mycardial infarction. IOSR J Dent. Med Sci. 2015;14:25–36. [Google Scholar]
  • 42.Kocyigit UM. The effect of oxytocin and oxytocin receptor antagonist atosiban on the carbonic anhydrase and acetylcholinesterase enzymes from lung tissues. Cumhuriyet Sci J. 2017;38:450–460. doi: 10.17776/csj.340483. [DOI] [PubMed] [Google Scholar]
  • 43.Sartain JB, Barry JJ, Howat PW, McCormack DI, Bryant M. Intravenous oxytocin bolus of 2 units is superior to 5 units during elective Caesarean section. Br J Anaesth. 2008;101:822–826. doi: 10.1093/bja/aen273. [DOI] [PubMed] [Google Scholar]
  • 44.Simpson Kathleen Rice, Knox G. Eric. OXYTOCIN AS A HIGH-ALERT MEDICATION. MCN, The American Journal of Maternal/Child Nursing. 2009;34(1):8–15. doi: 10.1097/01.NMC.0000343859.62828.ee. [DOI] [PubMed] [Google Scholar]
  • 45.Thomas JS, Koh SH, Cooper GM. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section. Br J Anaesth. 2007;98:116–119. doi: 10.1093/bja/ael302. [DOI] [PubMed] [Google Scholar]
  • 46.Archer TL, Knape K, Liles D, Wheeler AS, Carter B. The hemodynamics of oxytocin and other vasoactive agents during neuraxial anesthesia for cesarean delivery: findings in six cases. Int J Obstet Anesth. 2008;17:247–254. doi: 10.1016/j.ijoa.2008.03.003. [DOI] [PubMed] [Google Scholar]
  • 47.Grewen KM, Light KC. Plasma oxytocin is related to lower cardiovascular and sympathetic reactivity to stress. Biol Psychol. 2011;87:340–349. doi: 10.1016/j.biopsycho.2011.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Morin V, et al. Evidence for non-linear pharmacokinetics of oxytocin in anesthetizetized rat. Journal of pharmacy & pharmaceutical sciences: a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 2008;11:12–24. doi: 10.18433/J3PK5X. [DOI] [PubMed] [Google Scholar]
  • 49.Matute-Bello G, et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol. 2011;44:725–738. doi: 10.1165/rcmb.2009-0210ST. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The corresponding authors will provide data upon reasonable request.

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES